Immunomedics (IMMU) Reports Q2 Loss of $0.02

February 8, 2018 4:51 PM EST

Immunomedics (NASDAQ: IMMU) reported Q2 EPS of ($0.02), versus ($0.23) reported last year. Revenue for the quarter came in at $600 thousand, versus $40 thousand reported last year.

For earnings history and earnings-related data on Immunomedics (IMMU) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings